Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...
A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...
Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...
Drugs which have been studied include: Tricyclic antidepressants were considered the standard treatment for depression before SSRIs were developed. While these drugs are now used less often for ...
Although systematic reviews have outlined the current treatment options for neuropathic ... placebo-controlled trials investigating chronic dosing for neuropathic pain, in 10 or more patients ...